CU Medical Systems, Inc. (KOSDAQ:115480)
South Korea flag South Korea · Delayed Price · Currency is KRW
621.00
0.00 (0.00%)
At close: Oct 2, 2025

CU Medical Systems Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Operating Revenue
40,79140,62941,80346,95735,40228,319
Upgrade
Other Revenue
---0-0--
Upgrade
40,79140,62941,80346,95735,40228,319
Upgrade
Revenue Growth (YoY)
3.74%-2.81%-10.98%32.64%25.01%1.39%
Upgrade
Cost of Revenue
18,00119,16921,47922,30916,98015,928
Upgrade
Gross Profit
22,79021,46020,32424,64818,42212,391
Upgrade
Selling, General & Admin
10,36710,0299,1869,3128,0729,895
Upgrade
Research & Development
2,5872,1862,9122,6231,8451,355
Upgrade
Other Operating Expenses
185.61182.92108.32212.62100.1369.66
Upgrade
Operating Expenses
15,19214,10615,26413,36616,04721,261
Upgrade
Operating Income
7,5997,3545,06011,2822,376-8,870
Upgrade
Interest Expense
-1,528-1,147-325.57-454.24-1,136-3,135
Upgrade
Interest & Investment Income
353.52260.3189.7198.72162.01206.28
Upgrade
Earnings From Equity Investments
--105.46-52.92-
Upgrade
Currency Exchange Gain (Loss)
-106.71685.08-107.07311.12363.39-263.33
Upgrade
Other Non Operating Income (Expenses)
-529.32-720.52137.38-347.03-4,082-323.67
Upgrade
EBT Excluding Unusual Items
5,7886,4334,96010,891-2,264-12,386
Upgrade
Gain (Loss) on Sale of Investments
-10,461-9,214-9,637-1,024-8,046636.13
Upgrade
Gain (Loss) on Sale of Assets
-49.88-42.814.42861.77-63.41412.09
Upgrade
Asset Writedown
--1,004-2,781-370.57-5,267-6,869
Upgrade
Other Unusual Items
1,3531,353-87.97499.72-83.06
Upgrade
Pretax Income
-3,371-2,474-7,44310,446-15,140-18,290
Upgrade
Income Tax Expense
617.19666.52692.81934.62-999.212,459
Upgrade
Earnings From Continuing Operations
-3,988-3,141-8,1369,511-14,141-20,749
Upgrade
Earnings From Discontinued Operations
------4,832
Upgrade
Net Income to Company
-3,988-3,141-8,1369,511-14,141-25,581
Upgrade
Minority Interest in Earnings
-40.92-63.65-67.68-85.88160.15-158.78
Upgrade
Net Income
-4,029-3,204-8,2049,425-13,981-25,740
Upgrade
Net Income to Common
-4,029-3,204-8,2049,425-13,981-25,740
Upgrade
Shares Outstanding (Basic)
575148453422
Upgrade
Shares Outstanding (Diluted)
575148453422
Upgrade
Shares Change (YoY)
19.29%7.11%5.90%33.07%52.90%36.70%
Upgrade
EPS (Basic)
-70.18-62.58-171.59208.78-412.11-1160.04
Upgrade
EPS (Diluted)
-71.16-63.00-172.00208.78-412.11-1160.04
Upgrade
Free Cash Flow
14,079-5,9841,893-8,465-4,6967,133
Upgrade
Free Cash Flow Per Share
245.24-116.8639.59-187.50-138.42321.49
Upgrade
Gross Margin
55.87%52.82%48.62%52.49%52.04%43.76%
Upgrade
Operating Margin
18.63%18.10%12.11%24.03%6.71%-31.32%
Upgrade
Profit Margin
-9.88%-7.89%-19.63%20.07%-39.49%-90.89%
Upgrade
Free Cash Flow Margin
34.52%-14.73%4.53%-18.03%-13.26%25.19%
Upgrade
EBITDA
10,74510,0136,99512,9334,320-4,478
Upgrade
EBITDA Margin
26.34%24.64%16.73%27.54%12.20%-15.81%
Upgrade
D&A For EBITDA
3,1462,6581,9351,6511,9454,392
Upgrade
EBIT
7,5997,3545,06011,2822,376-8,870
Upgrade
EBIT Margin
18.63%18.10%12.11%24.03%6.71%-31.32%
Upgrade
Effective Tax Rate
---8.95%--
Upgrade
Advertising Expenses
-868.01817.01995.38194.38123.9
Upgrade
Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.